针对与非裔美国人乳腺癌相关的生殖基因突变的基因测试的挑战
S Kamaraju1, M Conroy2, A Harris2
1Medical College of Wisconsin, Milwaukee, WI, USA; Department of Medicine, Division of Hematology-Oncology, Medical College of Wisconsin, Milwaukee, WI, USA; Froedtert Hospital, Milwaukee, WI, USA.
Cancer treatment reviews
|February 7, 2024
概括
健康的社会决定因素为非洲裔美国人 (AAs) 的癌症护理创造了障碍. 解决这些不平等问题需要改善基因测试的准入和针对遗传性癌症风险的量身定制教育.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 健康差异 在健康上的差异
背景情况:
- 癌症查,诊断和治疗中的不平等导致劣质的结果.
- 健康的社会决定因素 (SDOH) 对获得癌症护理的机会构成重大障碍.
- 非洲裔美国人 (AAs) 面临着独特的挑战,包括更高的侵袭性癌症亚型和遗传突变率.
研究的目的:
- 审查在AA中限制基因测试的因素.
- 为了突出细菌突变增加癌症风险的细菌突变的流行,在AAs.
- 强调需要进行多小组生殖系检测和为服务不足的少数群体提供教育.
主要方法:
- 关于SDOH和癌症护理不平等的文献综述.
- 在AAS中分析生殖基因突变的流行率.
- 讨论少数民族遗传评估中的医生培训缺口.
主要成果:
- 运输,住房和粮食不安全等SDOH障碍延迟了查和治疗.
- 甲基抗原具有较高的三阴性乳腺癌和BRCA1/2突变的发病率.
- 经济不安全,健康素养低,缺乏意识阻碍了基因测试的普及.
结论:
- 由于特定突变的患病率较高,多面板生殖系检测对AA至关重要.
- 需要加强医生培训,以解决遗传评估和少数群体的医疗保健需求.
- 针对遗传性癌症风险的有针对性的教育对于服务不足的人群至关重要.
相关概念视频
Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...


